Zacks Investment Research on MSN3h
Novo Nordisk Expands Wegovy Price Cut Program, Stock Still Falls 2%
Novo Nordisk NVO announced an update to the savings offer for its popular obesity injection, Wegovy (semaglutide). This ...
New Atlas15h
Next-gen weight-loss drugs will be here within 12 months
It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...
Drug Delivery Business4h
Enable Injections wins CE mark for enFuse drug delivery device
Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.